TY - JOUR
T1 - Cigarette smoking and bladder cancer in men
T2 - A pooled analysis of 11 case-control studies
AU - Brennan, Paul
AU - Bogillot, Olivier
AU - Cordier, Sylvaine
AU - Greiser, Eberhard
AU - Schill, Walter
AU - Vineis, Paolo
AU - Lopez-Abente, Gonzalo
AU - Tzonou, Anastasia
AU - Chang-Claude, Jenny
AU - Bolm-Audorff, Ulrich
AU - Jöckel, Karl Heinz
AU - Donato, Francesco
AU - Serra, Consol
AU - Wahrendorf, Jorgen
AU - Hours, Martine
AU - T'Mannetje, Andrea
AU - Kogevinas, Manolis
AU - Boffetta, Paolo
PY - 2000
Y1 - 2000
N2 - The primary risk factor for bladder cancer is cigarette smoking. Using a combined analysis of I I case-control studies, we have accurately measured the relationship between cigarette smoking and bladder cancer in men. Available smoking information on 2,600 male bladder cancer cases and 5,524 male controls included duration of smoking habit, number of cigarettes smoked per day and time since cessation of smoking habit for ex-smokers. There was a linear increasing risk of bladder cancer with increasing duration of smoking, ranging from an odds ratio (OR) of 1.96 after 20 years of smoking (95% confidence interval [CI] 1.48-2.61) to 5.57 after 60 years (CI 4.18-7.44). A dose relationship was observed between number of cigarettes smoked per day and bladder cancer up to a threshold limit of 15'20 cigarettes per day, OR = 4.50 (CI 3.81-5.33), after which no increased risk was observed. An immediate decrease in risk of bladder cancer was observed for those who gave up smoking. This decrease was over 30% after I-4 years, OR = 0.65 (0.53-0.79), and was over 60% after 25 years of cessation, OR = 0.37 (0.30-0.45). However, even after 25 years, the decrease in risk did not reach the level of the never-smokers, OR = 0.20. (0.17-0.24). The proportion of bladder cancer cases attributable to ever-smoking was 0.66 (0.6 I-0.70) for all men and 0.73 (0.66-0.79) for men younger than 60. These estimates are higher than previously calculated. (C) 2000 Wiley-Liss, Inc.
AB - The primary risk factor for bladder cancer is cigarette smoking. Using a combined analysis of I I case-control studies, we have accurately measured the relationship between cigarette smoking and bladder cancer in men. Available smoking information on 2,600 male bladder cancer cases and 5,524 male controls included duration of smoking habit, number of cigarettes smoked per day and time since cessation of smoking habit for ex-smokers. There was a linear increasing risk of bladder cancer with increasing duration of smoking, ranging from an odds ratio (OR) of 1.96 after 20 years of smoking (95% confidence interval [CI] 1.48-2.61) to 5.57 after 60 years (CI 4.18-7.44). A dose relationship was observed between number of cigarettes smoked per day and bladder cancer up to a threshold limit of 15'20 cigarettes per day, OR = 4.50 (CI 3.81-5.33), after which no increased risk was observed. An immediate decrease in risk of bladder cancer was observed for those who gave up smoking. This decrease was over 30% after I-4 years, OR = 0.65 (0.53-0.79), and was over 60% after 25 years of cessation, OR = 0.37 (0.30-0.45). However, even after 25 years, the decrease in risk did not reach the level of the never-smokers, OR = 0.20. (0.17-0.24). The proportion of bladder cancer cases attributable to ever-smoking was 0.66 (0.6 I-0.70) for all men and 0.73 (0.66-0.79) for men younger than 60. These estimates are higher than previously calculated. (C) 2000 Wiley-Liss, Inc.
UR - https://www.scopus.com/pages/publications/0034074419
U2 - 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M
DO - 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M
M3 - Article
C2 - 10738259
AN - SCOPUS:0034074419
SN - 0020-7136
VL - 86
SP - 289
EP - 294
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 2
ER -